(CS) Glencore : Agriculture ambitions – food for thought

■ In this report we focus on Glencore's Agriculture ("Ag") growth ambitions. The right-sizing of the company's debt levels, formation of the 50:50 Ag JV last year and ongoing weakness in Ag trading conditions raises the prospect of industry M&A, in our view. On our analysis, Glencore has the balance sheet to fund a major transaction, increase the dividend payout at the half year and keep net debt within targeted metrics. We do not believe M&A will derail our core investment case and post the recent pull back we reiterate our OUTPERFORM rating. 
■ Agriculture landscape: Ag is the smallest of Glencore's three main commodity verticals and the industry is dominated by four long standing companies known as the "ABCD" group. Ag has been a targeted growth area for Glencore ever since its IPO in 2011 and its long term aim is to break into the US market and compete with the largest players. Realistically this would require a major acquisition (or a series of bolt-ons). Ag prices and margins have been on a three year downtrend, potentially making major players more open to transactions. However, given the weak returns history, any potential deal would need to come with a strong synergy/value creation angle. 
■ Deal funding capacity over $12bn: The formation of the 50:50 Ag JV last year provides the Ag division with greater financial firepower. By end 2017 we forecast Glencore net debt of $10bn and based on the company's through cycle net debt : EBITDA ceiling of 2x means Glencore has upwards of $6bn of funding capacity which, combined with the JV partners, could potentially provide the Ag division with upwards of $12bn of deal funding capacity. 
■ Valuation: We have made minor changes to our estimates following the Q117 production report. Our unchanged 410p target price is based on 2018E target EV/EBITDA multiple of 6.5x and marketing PE of 12x.

NYT : Forget Taxes, Warren Buffett Says. The Real Problem Is Health Care.



From: LAURENT CHEKROUN (MAKOR SECURITIES LO) At: 05/08/17 22:56:08
Subject: NYT : Forget Taxes, Warren Buffett Says. The Real Problem Is Health Care.
Forget Taxes, Warren Buffett Says. The Real Problem Is Health Care.

OMAHA — “The tax system is not crippling our business around the world.”

That was Warren E. Buffett, the chairman and chief executive of Berkshire Hathaway, over the weekend at the company’s annual meeting, known as the “Woodstock of capitalism.”

Mr. Buffett, in a remarkably blunt and pointed remark, implicitly rebuked his fellow chief executives, who have been lobbying the Trump administration and Washington lawmakers to lower corporate taxes.

In truth, Mr. Buffett said, a specter much more sinister than corporate taxes is looming over American businesses: health care costs. And chief executives who have been maniacally focused on seeking relief from their tax bills would be smart to shift their attention to these costs, which are swelling and swallowing their profits.

It was clarifying to hear Mr. Buffett frame things this way. The need for corporate tax relief has become the lodestar of the corner office, with C.E.O.s rhapsodizing over President Trump’s plan to try to stimulate growth by cutting tax rates for businesses.

Continue reading the main story
RELATED COVERAGE


Warren Buffett, at Berkshire Meeting, Condemns Republican Health Care Bill MAY 6, 2017

DEALBOOK
Warren Buffett Holds Forth on Sharing the Wealth MAY 2, 2016

DEALBOOK
Berkshire’s Warren Buffett Shows His Teddy Bear Image Has Tough Side MAY 4, 2015

DEALBOOK
A Warning From Buffett About Banks MARCH 2, 2015
But as Mr. Buffett pointed out, these chief executives are missing the bigger issue — the one that should be their Holy Grail. As a percentage of our gross domestic product, the cost of maintaining our American health care system — hospitals, H.M.O.s, doctor visits, prescription drugs, medical devices, insurance companies, Medicare, Medicaid — is rising at an alarming rate. And Corporate America pays a big (and growing) chunk of the bill.

We’re not talking about the cost of health insurance, which is a fraction of the overall cost.

Today’s corporate tax rates, Mr. Buffett seemed to suggest, are a distraction, not a true impediment to growth.

“If you go back to 1960 or thereabouts, corporate taxes were about 4 percent of G.D.P.,” Mr. Buffett said. “I mean, they bounced around some. And now, they’re about 2 percent of G.D.P.”

By contrast, he said, while tax rates have fallen as a share of gross domestic product, health care costs have ballooned. About 50 years ago, he said, “health care was 5 percent of G.D.P., and now it’s about 17 percent.”

His is one of the most cogent arguments for renewing attention on the underlying costs of our health care system — an issue far beyond the debate around the Affordable Care Act and what it is going to look like if it is repealed and replaced.

Mr. Buffett said our global competitiveness had fallen largely because our businesses were paying far more for health care — a tax by another name — than those in other countries.

At his annual shareholders’ conference, which drew tens of thousands of people to Omaha, he gave a virtual seminar on the economics of health care that chief executives and lawmakers would be helped by hearing. He demonstrated in stark terms that the constant refrain from the business community about taxes should probably be redirected toward trying to bend the cost curve of health care.

“When American business talks about strangling our competitiveness, or that sort of thing, they’re talking about something that as a percentage of G.D.P. has gone down,” Mr. Buffett said. “While medical costs, which are borne to a great extent by business,” have swelled.

He is right: In 1960, corporate taxes in the United States were about 4 percent of G.D.P., which is probably the best way to measure the burden on businesses. Then the percentage fell steadily, reaching its bottom in 1983 before rising slightly over the last several decades. Today, it is 1.9 percent.

In the meantime, health care costs as a percent of G.D.P. have skyrocketed, significantly diverging with those of other industrial countries. Our health care costs stand at 17.1 percent of G.D.P., up from 13.1 percent in 1995.

The figure in Germany is only 11.3 percent, up from 9.4 percent during the same period. Japan’s is 10.2 percent, up from 6.6 percent. Britain’s health care costs are 9.1 percent of G.D.P., up from 6.7 percent in 1995. And China’s is only at 5.5 percent, up from 3.5 percent.

That puts the United States at a material disadvantage far beyond the tax differential. And it harms American companies in particular, since they bear such a big share of those costs. Corporations spend $12,591 on average for coverage of a family of four, up 54 percent since 2005, according to a study by the Kaiser Family Foundation.

“Medical costs are the tapeworm of American economic competitiveness,” Mr. Buffett said, using a metaphor he has employed in the past to describe the insidious and parasitic costs of our health care system.

Mr. Buffett is a Democrat, but his business partner, Charles T. Munger, is a Republican — and a rare one who has advocated a single-payer health care system. Under his plan, which Mr. Buffett agrees with, the United States would enact a sort of universal type of coverage for all citizens — perhaps along the lines of the Medicaid system — with an opt-out provision that would allow the wealthy to still get concierge medicine.

Our bloated health care system, Mr. Buffett asserted, is the true barrier to America’s world competitiveness as well as “the single biggest variable where we keep getting more and more out of whack with the rest of the world.”

But people don’t talk about it enough. “It’s very tough for political parties to attack it, but it’s basically a political subject,” Mr. Buffett said in reply to a question I had posed. (I was one of three journalists and three analysts who, along with shareholders, peppered Mr. Buffett and Mr. Munger with questions during the meeting.)

That’s not to say corporate tax reform won’t help, but it is tiny relative to fixing health care.

Indeed, Mr. Buffett said, even if Washington put in place a tax credit for capital investment, he did not think that BNSF — the railroad company he owns, which spends billions on fixing rail tracks — would do its job faster or better because of the potential tax credit.

“I can’t recall sending anything out to our managers saying, ‘Let’s do this because the tax law is going to change,’” Mr. Buffett said.

Mr. Munger, the vice chairman of Berkshire Hathaway, added: “We’re not going to change anything at the railroad just for some little tax jiggle.”

Neither man, however, is expecting the bigger tax — health care — to be fixed anytime soon.

“On this issue, both parties hate each other so much that neither one can think rationally, and I don’t think that helps, either,” Mr. Munger said.

>>> What to look at today - 9th of May 2017

Dow +0.03% S&P +0.0% Nasdaq +0.03% Russell -0.38%
Nasdaq at record as APPLE +2.7% closed at record (Drexel bullish call). JD earnings led nasdaq100 (NDX). Macro non-event and 2017 Ira Sohn Investment Conference took center stage (some individual names reacted). Rates higher helped banks, but copper lower on China trade balance, and leaned on commodities again. $16.9b worth of M&A was announced in North America yesterday, so put a floor to the market. Also JPY recouped 113, so helped sentiment. Energy subgroups acted well too (as Crude rallied +60bps on chatters on prodn cut extension). Overall volumes weak, came at 6.27bn shares, so down -4% vs 20day ave. Earnings pick up today as 23 of SPX due with EPS (TMT a focus, specifically media). Though we did not have any major macro data, the CESIUSD index (+ve macro index) fell again today. Note that VIX closed at 9.77 (down -8%), historic low. FN +9%, QTNA +8%, TDOC / MAR / RGR +5% higher following earnings/guidance, RAD +3.2% on M&A update... HTZ -17%, OTEX -10%, CBI -6% following earnings/guidance. Asia indices mixed after a flat day on Wall St where S&P500 hit record intraday high and Vix saw a multi-year low. Australia underperforming ahead of the release of its FY17/18 budget, with retailers slumping on much weaker than expected Aussie Retail Sales. CBA shares also trading lower following Q3 results. AUD/USD fell nearly 40pips toward 0.7350 on the release.- Japan wage inflation posted its biggest y/y decline in nearly 2 years, and BOJ Gov Kuroda noted central bank is prepared to do more policy adjustment if needed, sending USD/JPY pair to session highs near 113.40.

Nikkei -0.15% Hang Seng +0.38% CSI -0.58% Shanghai -0.38%

Eur$ 1.0924 CNH 6.9108 CNY 6.9071 JPY 113.36 GBP 1.2954 CHF 0.9989 RUB 58.3793 WTI$ 46.36 -0.15%

S&P -0.04% EuroStoxx +0.30% FTSE +0.16% Dax +0.12% SMI +0.12%

Macro :
- Berkshire Eyeing German Cos But High Prices Remain Obstacle: HB
- Oil’s Drop No Threat to Stocks as in 2015, Morgan Stanley Says
- China April Retail Auto Sales Fall 1.7% on Year: PCA
- Saudi Arabia Has Better Chance to Join FTSE Russell Than China

Keep an eye on :
- ABE SM : Atlantia Said Mulling EU16/Share Bid for Abertis: Confidencial
- ADEN VX : Adecco 1Q Revenue Beats Estimates Up 7% as Italy Surges
- AGFB BB : Agfa-Gevaert 1Q Revenue Beats Est.
- AKZA NA : Elliott Files Enterprise Chamber Petition Regarding Akzo EGM
- MO US : Philip Morris, Altria Combination by 2019 Has 50/50 Chance: BI
- BCP PL : BCP 1Q Net Income EU50.1m
- CNA LN : Centrica CEO Suggests Taxpayers May Pay Some Clean-Energy Costs
- COFB BB : Cofinimmo Spends EU21m on Expansion in Dutch Health-Care Assets
- CBK GY : Commerzbank Posts 1Q Net Income of EU217m vs EU74m Estimate
- DAI GY : DHL, Daimler Team Up to Fend Off Amazon’s Logistics Challenge
- DIA IM : DiaSorin 1Q Ebit Beats Est.
- DLG GY : Dialog Semiconductor 1Q Revenue Up 12%; Sees Further Rev. Growth
- EOAN GY : EON 1Q Adjusted Net Falls 20% to EU525m, Missing Estimate
- ZIL2 GY : ElringKlinger 1Q Sales Beat Highest Est.
- EUCAR FP : Europcar 1Q Revenue EU439m, Hertz Down 15% Post-Mkt; 1Q U.S. Rental Car Revenue Falls 4% Y/y
- FRA GY : Frankfurt Airport April Traffic Jumps 10% as Group Debt to Rise
- G1A GY : GEA Group Wants to See 2Q Business Before Giving FY Forecast
- SDF GY : K+S 1Q Operating Income Beats Est.
- MRL SM : Popular to Sell Stake in Merlin, El Confidencial Reports
- MUV2 GY : Munich Re 1Q Operating Profit Misses Est.
- NYR BB : Marshall Wace Expands Nyrstar Short Position as Och-Ziff Reduces
- NOVN VX : Novartis Reports New 11.1% Altimmune Passive Stake
- ORK NO : Orkla 1Q Revenue Misses Est.
- PNDORA DC : Pandora 1Q Net Beats Estimates; FY Outlook Maintained
- PLT IM : Parmalat Sees FY Rev. Change In Constant Currency +4%
- SAN FP : Sanofi Plans to Keep Cepia Ingredients Unit, Les Echos Reports
- SY1 GY : Symrise 1Q Sales Miss Est.
- TSLA LN : Social Capital’s Palihapitiya Likes Tesla 2022 Convertible Bonds
- TSN US : Tyson May Mull M&A Again After Integrating AdvancePierre: CEO
- UN01 GY : Uniper Profit Falls 41% as One-Time Trading Effects Don’t Repeat

>>> Europe : Brokers Upgrades & Downgrades - 9th of May 2017

>>> Up
*Autoliv Raised to Buy at Jefferies
*Baloise Raised to Buy at UBS, PT CHF160
*DNB Raised to Overweight at Morgan Stanley, PT NOK165
*Evonik Raised to Buy at SocGen, PT EU36
*Skanska Raised to Hold at SEB Equities, PT SEK199
*Spirent Raised to Buy at Citi, PT 145p
*Subsea 7 Raised to Neutral at Goldman, PT NOK132.90

>>> Down
*Close Brothers Cut to Underperform at Macquarie, PT GBP14.30
*Faurecia Cut to Hold at Jefferies
*Kuehne + Nagel Cut to Underweight at JPMorgan, PT CHF140
*Solvay Cut to Hold at HSBC, PT EU125

>>> Initiation
*AA New Neutral at Credit Suisse, PT 275p

>>> Call

>>> US After Hours Summary: FN +9%, QTNA +8%, TDOC / MAR / RGR +5% high


After Hours Summary: FN +9%, QTNA +8%, TDOC / MAR / RGR +5% higher following earnings/guidance, RAD +3.2% on M&A update... HTZ -17%, OTEX -10%, CBI -6% following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: EGY +26.3%, FN +9.4%, QTNA +7.7%, SBRA +6.6% (ticking higher), AEZS +5.6%, TDOC +5.1%, NVAX +4.9%, BLDR +4.8%, MAR +4.6%, RGR +4.6% (also announces expansion of its stock repurchase program to $100 million), TCMD +4.3%, GPOR +2.9%, P +2.9% (also KKR invests $150 mln in convertible preferred stock; Board also forming independent committee to look for new Directors), BKD +2.8%, OAS +1.1% (also announces plans for an initial public offering of certain of its midstream assets), RBC +1% (light volume)

Companies trading higher in after hours in reaction to news: CLNT +40.7% (YSK 1860 disclosed 29.4% active stake pursuant to Share Purchase Agreement), ROKA +14.6% (thinly traded; enters 5-year non-exclusive distribution agreement with FoodChek Systems Inc. to distribute their lines of both proprietary Actero ELITE Enrichment Media and non-proprietary Actero UNIVERSAL Enrichment Media), ORIG +10.3% (announces the deadline for holders of term loans of Drillships Financing Holding and Drillships Ocean Ventures has been extended), DHXM +7.1% (continued strength following Sohn mention), RAD +3.2% (Rite Aid and Walgreens certify substantial compliance with second request), LNTH +3.2% (to join S&P SmallCap 600), XRAY +2.8% (ticking higher ahead of earnings tomorrow before the open), VVV +2.4% (to join S&P MidCap 400), NRG +2.4% (still checking), MXL +2% (to join S&P SmallCap 600), DPLO +1.6% (completes acquisition of WRB Communications for $24.5 million cash and $4.5 million of Diplomat common stock), DXC +1.3% (positive mention by Glenview Capital's Larry Robbins at Sohn)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: SCYX -21.3% (also provided IV formulation development status update), HTZ -17.1%, ALIM -16.6%, NVRO -14.6%, OTEX -10.4%, MEET -9.7%, ARTX -7.6%, CBI -6.4%, ADUS -5.1%, PRCP -4.3% (light volume), JCOM -4.2%, POST -4%, PLOW -3.5%, AKAO -3.4% (also files mixed securities shelf offering), AFSI -1.7%, TSO -1.1%

Companies trading lower in after hours in reaction to news: CYTK -6.7% (commences $75 mln common stock offering), AHH -4.4% (commenced an underwritten public offering of 6,000,000 shares of its common stock), GAIN -4.2% (announces public common stock offering), APTS -3.9% (commences 2.75 mln common stock offering), FTR -3.9% (lower after Jericho Capital Asset Management's Josh Resnick cautious comments at Sohn conference), CAR -1.8% (HTZ sympathy), DSW -1.7% (downgraded at Buckingham)

>>> Pandora Media beats by $0.13, reports revs in-line; guides Q2 revs below con

Pandora Media beats by $0.13, reports revs in-line; guides Q2 revs below consensus; lowers FY17 rev guidance; KKR (KKR) invests $150 mln in convertible preferred stock, get Board seat; Board also forming independent committee to look for new Directors (10.40)
  • Reports Q1 (Mar) loss of $0.20 per share, $0.13 better than the Capital IQ Consensus of ($0.33); revenues rose 6.3% year/year to $316 mln vs the $318.15 mln Capital IQ Consensus. Advertising revenue was $223.3 million, a 1% year-over-year increase, during our seasonally weakest advertising quarter. Total subscribers increased from 3.93 million in Q1 2016 to 4.71 million in Q1 2017, growing ~20% year-over-year. Subscription and other revenue was $64.9 million, a 19% year-over-year increase. Adj. EBITDA ($71.3) mln vs. ($70-80) mnln guidance
  • Co issues downside guidance for Q2, sees Q2 revs of $360-375 mln vs. $390.79 mln Capital IQ Consensus Estimate; EBITDA loss $50-65 mln.
  • Co issues in-line guidance for FY17, sees FY17 revs of $1.50-1.65 bln from $ vs. $1.62 bln Capital IQ Consensus Estimate.
  • Pandora successfully launched its on-demand subscription product, Pandora Premium, during the quarter. ~1.3 million trials were started in the last seven weeks, including more than 500 thousand Premium trial starts. Total subscribers increased approximately 20% year-over-year. To date, more than 80% of new trial subscribers were acquired on-platform—virtually free of acquisition costs—again demonstrating our marketplace strategy in action. Nearly half of Premium trial listeners used Pandora daily during their first week, significantly higher than non-Premium listeners. Research tells us that more than 30% of our ad-supported and paid radio listeners are strong candidates for an on-demand tier.
  • entered into an agreement for a $150 million strategic investment from KKR. In connection with the investment, Richard Sarnoff, KKR's Head of Media & Communications Private Equity investing in the Americas, will join Pandora's Board of Directors. KKR will purchase an aggregate of $150 million in a new designated Series A convertible preferred stock of Pandora. Pandora will pay dividends to the holders of the preferred stock quarterly at an annualized rate of 7.5% if paid in cash or 8% if paid in kind, at its option. The Series A preferred stock is convertible into common stock, cash or a combination thereof at a conversion price of $13.50 per share. The offering may be upsized to a total of $250 million should the Company determine to issue additional shares.
  • Company is implementing certain governance changes. James M. P. Feuille and Peter Gotcher will resign from the Board of Directors, and the Board is forming an independent committee, to be chaired by Timothy Leiweke, an independent director, to identify and appoint new directors who will provide additional expertise and leadership as the Company moves forward. In addition, at the upcoming 2017 annual meeting of stockholders, the Board will recommend that its stockholders approve a resolution to declassify the Board and provide for the annual election of directors in the future

NYT : Forget Taxes, Warren Buffett Says. The Real Problem Is Health Care.

Forget Taxes, Warren Buffett Says. The Real Problem Is Health Care.

OMAHA — “The tax system is not crippling our business around the world.”

That was Warren E. Buffett, the chairman and chief executive of Berkshire Hathaway, over the weekend at the company’s annual meeting, known as the “Woodstock of capitalism.”

Mr. Buffett, in a remarkably blunt and pointed remark, implicitly rebuked his fellow chief executives, who have been lobbying the Trump administration and Washington lawmakers to lower corporate taxes.

In truth, Mr. Buffett said, a specter much more sinister than corporate taxes is looming over American businesses: health care costs. And chief executives who have been maniacally focused on seeking relief from their tax bills would be smart to shift their attention to these costs, which are swelling and swallowing their profits.

It was clarifying to hear Mr. Buffett frame things this way. The need for corporate tax relief has become the lodestar of the corner office, with C.E.O.s rhapsodizing over President Trump’s plan to try to stimulate growth by cutting tax rates for businesses.

Continue reading the main story
RELATED COVERAGE


Warren Buffett, at Berkshire Meeting, Condemns Republican Health Care Bill MAY 6, 2017

DEALBOOK
Warren Buffett Holds Forth on Sharing the Wealth MAY 2, 2016

DEALBOOK
Berkshire’s Warren Buffett Shows His Teddy Bear Image Has Tough Side MAY 4, 2015

DEALBOOK
A Warning From Buffett About Banks MARCH 2, 2015
But as Mr. Buffett pointed out, these chief executives are missing the bigger issue — the one that should be their Holy Grail. As a percentage of our gross domestic product, the cost of maintaining our American health care system — hospitals, H.M.O.s, doctor visits, prescription drugs, medical devices, insurance companies, Medicare, Medicaid — is rising at an alarming rate. And Corporate America pays a big (and growing) chunk of the bill.

We’re not talking about the cost of health insurance, which is a fraction of the overall cost.

Today’s corporate tax rates, Mr. Buffett seemed to suggest, are a distraction, not a true impediment to growth.

“If you go back to 1960 or thereabouts, corporate taxes were about 4 percent of G.D.P.,” Mr. Buffett said. “I mean, they bounced around some. And now, they’re about 2 percent of G.D.P.”

By contrast, he said, while tax rates have fallen as a share of gross domestic product, health care costs have ballooned. About 50 years ago, he said, “health care was 5 percent of G.D.P., and now it’s about 17 percent.”

His is one of the most cogent arguments for renewing attention on the underlying costs of our health care system — an issue far beyond the debate around the Affordable Care Act and what it is going to look like if it is repealed and replaced.

Mr. Buffett said our global competitiveness had fallen largely because our businesses were paying far more for health care — a tax by another name — than those in other countries.

At his annual shareholders’ conference, which drew tens of thousands of people to Omaha, he gave a virtual seminar on the economics of health care that chief executives and lawmakers would be helped by hearing. He demonstrated in stark terms that the constant refrain from the business community about taxes should probably be redirected toward trying to bend the cost curve of health care.

“When American business talks about strangling our competitiveness, or that sort of thing, they’re talking about something that as a percentage of G.D.P. has gone down,” Mr. Buffett said. “While medical costs, which are borne to a great extent by business,” have swelled.

He is right: In 1960, corporate taxes in the United States were about 4 percent of G.D.P., which is probably the best way to measure the burden on businesses. Then the percentage fell steadily, reaching its bottom in 1983 before rising slightly over the last several decades. Today, it is 1.9 percent.

In the meantime, health care costs as a percent of G.D.P. have skyrocketed, significantly diverging with those of other industrial countries. Our health care costs stand at 17.1 percent of G.D.P., up from 13.1 percent in 1995.

The figure in Germany is only 11.3 percent, up from 9.4 percent during the same period. Japan’s is 10.2 percent, up from 6.6 percent. Britain’s health care costs are 9.1 percent of G.D.P., up from 6.7 percent in 1995. And China’s is only at 5.5 percent, up from 3.5 percent.

That puts the United States at a material disadvantage far beyond the tax differential. And it harms American companies in particular, since they bear such a big share of those costs. Corporations spend $12,591 on average for coverage of a family of four, up 54 percent since 2005, according to a study by the Kaiser Family Foundation.

“Medical costs are the tapeworm of American economic competitiveness,” Mr. Buffett said, using a metaphor he has employed in the past to describe the insidious and parasitic costs of our health care system.

Mr. Buffett is a Democrat, but his business partner, Charles T. Munger, is a Republican — and a rare one who has advocated a single-payer health care system. Under his plan, which Mr. Buffett agrees with, the United States would enact a sort of universal type of coverage for all citizens — perhaps along the lines of the Medicaid system — with an opt-out provision that would allow the wealthy to still get concierge medicine.

Our bloated health care system, Mr. Buffett asserted, is the true barrier to America’s world competitiveness as well as “the single biggest variable where we keep getting more and more out of whack with the rest of the world.”

But people don’t talk about it enough. “It’s very tough for political parties to attack it, but it’s basically a political subject,” Mr. Buffett said in reply to a question I had posed. (I was one of three journalists and three analysts who, along with shareholders, peppered Mr. Buffett and Mr. Munger with questions during the meeting.)

That’s not to say corporate tax reform won’t help, but it is tiny relative to fixing health care.

Indeed, Mr. Buffett said, even if Washington put in place a tax credit for capital investment, he did not think that BNSF — the railroad company he owns, which spends billions on fixing rail tracks — would do its job faster or better because of the potential tax credit.

“I can’t recall sending anything out to our managers saying, ‘Let’s do this because the tax law is going to change,’” Mr. Buffett said.

Mr. Munger, the vice chairman of Berkshire Hathaway, added: “We’re not going to change anything at the railroad just for some little tax jiggle.”

Neither man, however, is expecting the bigger tax — health care — to be fixed anytime soon.

“On this issue, both parties hate each other so much that neither one can think rationally, and I don’t think that helps, either,” Mr. Munger said.